Ministry of Health of Russian Federation

Russian Academy of Medical Sciences

Interregional Association for Clinical Microbiology
and Antimicrobial Chemotherapy
(IACMAC)

20-21 June 2001
Moscow, Russian Federation
Conference Venue: Russian Academy of State Service (RASS)
of the President of the Russian Federation

WITH PARTICIPATION OF

American Society for Microbiology (ASM)

European Commission (EC)

European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

Federation of European Societies for Chemotherapy and for Infection (FESCI)

International Society for Infectious Diseases (ISID)

Paul-Erlich Gesellschaft (PEG)

Tuesday, 19 June 2001

Round-table discussion RESPIRATORY FLUOROQUINOLONES Supported by "Aventis Pharma" 19.00 - 19.20 Evolution of fluoroquinolones as drugs for treatment of respiratory tract infections A. Bryskier (France) 19.20 - 19.40 Fluoroquinolones activity against Gram-positive cocci: results of multicenter study in Russia L. Stratchounski (Russia) 19.40 - 20.00 Management of pneumonia: advantages of monotherapy A. Chuchalin (Russia) 20.00 - 20.20 The role of fluoroquinolones in the modern therapy regimens A. Sinopalnikov (Russia) 20.20 - 20.30 General discussion

Wednesday, 20 June 2001

9.00 - 9.15 Opening ceremony V. Pokrovsky (Russia), S. Tkachenko (Russia), J. Acar (France), S. Lerner (USA) PLENARY SESSION. Main Hall Co-chairmen: A. Egorov (Russia), C.E. Nord (Sweden), V. Pokrovsky (Russia) 9.15 - 9.40 History of antibioticotherapy in Russia: lessons for the New Millennium Yu. Dudnik (Russia)   9.40 - 10.05 Current state of antimicrobial resistance in Europe H. Goossens (Belgium) 10.05 - 10.25 Antimicrobial resistance in Russia L. Stratchounski (Russia) 10.25 - 10.35 Coffee break 10.35 - 11.00 Modern achievements in antibacterial therapy: where are we now? A. Bryskier (France) 11.00 - 11.25 Strategy of the virulence of microorganisms S. Sidorenko (Russia) 11.25 - 11.50 Clinical significance of the microecology disturbances during antibacterial therapy C.E. Nord (Sweden) 11.50 - 12.15 Coffee break

SYMPOSIA SESSION Symposium I. Hall 3 Modern tendencies in the therapy of mycoses Co-chairmen: S. Burova (Russia), N. Klimko (Russia), M. Richardson (UK) Supported by "Gilead" and "Pfizer" 12.15 - 12.45 Modern antifungals for the therapy of invasive mycoses M. Richardson (UK) 12.45 - 13.05 Candidemia and acute disseminated candidosis in ICU patients N. Klimko (Russia) 13.05 - 13.25 Diagnosis and treatment of invasive aspergillosis A. Maschan (Russia) 13.25 - 14.00 Current approaches to the management of fungal urinary tract infections K. Naber (Germany) 14.00 - 15.00 Lunch Symposium II. Main Hall Policy of the selection of antibacterial agents in ICUs Co-chairmen: B. Gelfand (Russia), L. Stratchounski (Russia), S. Yakovlev (Russia) Supported by "Merck, Sharp & Dohme" 12.15 - 12.35 Pharmacological and microbiological basis for usage of carbapenems S. Yakovlev (Russia) 12.35 - 13.05 De-escalation therapy of serious infections À. Rodloff (Germany) 13.05 - 13.25 Role of carbapenems in the therapy of infections caused by ESBL-producing microorganisms L. Stratchounski (Russia) 13.25 - 13.45 Algorithms of the management of patients with surgical sepsis Russia B. Gelfand (Russia) 13.45 - 14.00 General discussion 14.00 - 15.00 Lunch Symposium III. Main Hall New possibilities of therapy of serious bacterial infections Co-chairmen: A. Rodloff (Germany), S. Sidorenko (Russia), L. Stratchounski (Russia) Supported by "Pfizer" 15.00 - 15.30 In vitro activity of sulperazone and its implications for clinical practice À. Rodloff (Germany) 15.30 - 16.00 Modern tendencies in the empiric therapy of patients with intra-abdominal infections L. Stratchounski (Russia) 16.00 - 16.30 Position of b-lactam/b-lactamase inhibitor combinations in lung infections H. Lode (Germany) 16.30 - 17.00 Optimization of selection of antibacterial drugs in immunocompromised patients G. Klyasova (Russia) 17.00 - 17.30 Clinical experience with b-lactam/b-lactamase inhibitors V. Korten (Turkey) Symposium IV. Hall 3 Surveillance of diphtheria in Europe and Russian Federation Co-chairmen: A. Efstratiou (UK), P. Grimont (France), N. Maksimova (Russia) Within the remit of the European Commission DG RTD INCO Copernicus programme IC15.CT.98.0302 15.00 - 15.30 Current situation with diphtheria in Europe: role of EC programmes in microbiological surveillance of diphtheria A. Efstratiou (UK) 15.30 - 16.00 Laboratory diagnosis of diphtheria I. Mazurova (Russia) 16.00 - 16.30 Molecular typing of Corynebacterium spp. The C.diphtheriae ribotype project P. Grimont (France) 16.30 - 17.00 Control and management of diphtheria: WHO view N. Emiroglu (Denmark) 17.00 - 17.30 General discussion

Thursday, 21 June 2001

PLENARY SESSION. Main Hall Co-chairmen: H. Giamarellou (Greece), Yu. Lobzin (Russia), A. Firsov (Russia) 9.00 - 9.25 Bioterrorism: role of antimicrobial agents E. Rubinstein (Israel) 9.25 - 9.50 Clinical significance of antibiotic influence of antibiotics on immunity M.-T. Labro (France)   9.50 - 10.15 Problems of antibiotic prophylaxis in surgery L. Zueva (Russia) 10.15 - 10.30 Coffee break 10.30 - 11.00 Antibiotic policy in hospital settings H. Giamarellou (Greece) 11.00 - 11.30 Epidemiology of resistance in Streptococcus pneumoniae P. Appelbaum (USA) 11.30 - 12.00 Reasons for non-efficacy of antibiotics J. Acar (France) 12.00 - 12.05 Result of ðThe Best posterñ competition

SYMPOSIA Symposium V. Hall 3 Perspectives of anti-infective therapy in the new millennium Co-chairmen: Yu. Belousov (Russia), B. Gelfand (Russia), P. Dellinger (USA) Supported by "GlaxoSmithKline" 10.00 - 10.20 Principles of development of antibiotic formulary for multi-purpose hospitals based on pharmacoeconomic approach Yu. Belousov (Russia) 10.20 - 10.40 Rational antibacterial therapy of nosocomial pneumonia A. Sinopalnikov (Russia) 10.40 - 11.20 Antibiotic prophylaxis for scheduled surgical procedures P. Dellinger (USA) 11.20 - 11.40 Algorithms of antimicrobial therapy in critical neutropenia G. Klyasova (Russia) 11.40 - 12.00 Place of mupirocin in eradication of staphylococcal carriage N. Dmitrieva (Russia) Symposium VI. Main Hall Federal guidelines for physicians as a tool for optimization of antimicrobial therapy Co-chairmen: Yu. Belousov (Russia), H. Lode (Germany), À. Tzoi (Russia) Under auspices of All-Russian Public Foundation "Human Health" and PEG 12.15 - 12.40 From clinical guidelines and standards to Federal guidelines for phisicians for usage of pharmaceutical agents Yu. Belousov (Russia) 12.40 - 13.05 Practice of usage of drug formulary in pneumonia H. Lode (Germany) 13.05 - 13.35 Peculiarities and stages of development of regional formulary of antimicrobials A. Shalunov (Russia) 13.35 - 14.00 Rational choice of antibiotics for the therapy of gram-positive infections S. Yakovlev (Russia) 14.00 - 15.00 Lunch Symposium VII. Molecular epidemiology and diagnostics of bacterial infections Co-chairmen: M. Achtman (Germany), E. Kaczmarski (UK), A. Platonov (Russia) 12.15 - 12.40 Molecular epidemiology of bacterial infections M. Achtman (Germany) 12.40 - 13.00 Genetic methods for detection of antibacterial resistance M. Edelstein (Russia) 13.00 - 13.30 Non-cultural methods of diagnosis of meningococcal infections E. Kaczmarski (UK) 13.30 - 14.00 Genodiagnostics and genotyping of pathogens causing bacterial meningitis in Russia A. Platonov (Russia) 14.00 - 14.30 Lunch Symposium VIII. Main Hall Position of parenteral cephalosporins in the therapy of nosocomial infections Co-chairmen: J. Acar (France), V. Rudnov (Russia), S. Sidorenko (Russia) Supported by "Brisol-Mayers Squibb" 15.00 - 15.30 New trends in etiology of infections in ICUs J. Acar (France) 15.30 - 16.00 Usage of cephalosporins for the therapy of pseudomonal infections S. Sidorenko (Russia) 16.00 - 16.30 Pharmacoeconomic approaches to the selection of cephalosporins V. Rudnov (Russia) 16.30 - 17.00 Current views on the therapy of nosocomial pneumonia R. Kozlov (Russia) 17.00 - 17.30 General discussion Symposium IX. Hall 3 Perspectives of usage of new fluoroquinolones Co-chairmen: E. Rubinstein (Israel), L. Stratchounski (Russia), V. Yakovlev (Russia) 15.00 - 15.30 Modern problems of antibacterial therapy of respiratory infections E. Rubinstein (Israel) 15.30 - 16.00 Antimicrobial resistance in Russia and respiratory fluoroquinolones L. Stratchounski (Russia) 16.00 - 16.30 Place of fluoroquinolones in therapy of acute exacerbations of chronic bronchitis À. Synopalnikov (Russia) 16.30 - 17.00 Strategy of choice of antibiotics in ambulatory practice. Possibilities of usage of respiratory fluoroquinolones S. Yakovlev (Russia) 17.00 - 17.30 General discussion